2m 2m 2m 2m 2m 2m 2m
BLUEJAY DIAGN (BJDX)
NASDAQ
$4.41+$0.07 (+1.61%)
Price as of Jun 03, 2026 7:54 PM EDT- $2.2MMarket Cap
- -39.04%1-Year Change
- Medical DevicesIndustry
BLUEJAY DIAGN (BJDX)
$4.41+$0.07 (+1.61%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | 249,040 +167.77% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | 200,129 N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 -100.00% | 48,911 +113.31% | |
Sales and Marketing Expense | N/A N/A | 8,297 -97.07% | 283,443 -37.21% | 451,421 +55.81% | |
Research and Development Expense | -3.0M -12.25% | -3.5M -39.25% | -5.7M +37.63% | -4.2M +261.70% | |
Depreciation and Amortization Expense | 74,182 -1.90% | 75,618 -88.34% | 648,708 +314.25% | 156,598 +7.47% | |
Total Operating Expenses | 7.0M -3.02% | 7.2M -30.47% | 10.3M +10.08% | 9.4M +189.98% | |
Operating Profit | -7.0M -3.02% | -7.2M -30.47% | -10.3M +10.66% | -9.3M +188.46% | |
Interest Income | 97,559 -33.10% | 145,823 -11.57% | 164,900 N/A | N/A N/A | |
Interest Expense | -807,797 0.00% | -807,797 N/A | N/A N/A | -6,360 -98.27% | |
Interest Income and Expense and Net | -710,238 +7.29% | -661,974 -501.44% | 164,900 +2,692.77% | -6,360 -98.27% | |
Total Nonoperating Income and Expense | 104,489 +119.06% | -548,178 -253.41% | 357,329 +1,615.62% | 20,828 +108.07% | |
Income before Taxes | -6.8M -67.30% | -20.9M +103.09% | -10.3M +10.66% | -9.3M +188.46% | |
Income Taxes | 31.3M +37.28% | 22.8M +39.88% | 16.3M N/A | N/A N/A | |
Extraordinary Items | 42,937 N/A | N/A N/A | 1,787 N/A | N/A N/A | |
Net Income | -6.8M -11.26% | -7.7M -22.46% | -10.0M +7.07% | -9.3M +166.52% | |
Net Income from Continuing Operations Applicable to Common | -6.8M -67.30% | -20.9M +110.38% | -10.0M +7.07% | -9.3M +166.52% | |
Basic EPS and Net Income | -15.25 -86.65% | -114.19 +1,157.60% | -9.08 +1,873.91% | -0.46 +12.20% | |
Diluted EPS and Net Income | -15.25 -86.65% | -114.19 +1,157.60% | -9.08 +1,873.91% | -0.46 +12.20% | |
Basic Weighted Average Shares | 449,043 +144.85% | 183,392 -83.27% | 1.1M -94.56% | 20.2M +136.60% | |
Diluted Weighted Average Shares | 449,043 +144.85% | 183,392 -83.27% | 1.1M -94.56% | 20.2M +136.60% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.2M +20.06% | 4.3M +94.79% | 2.2M -78.17% | 10.1M -46.90% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 5.2M +20.06% | 4.3M +94.79% | 2.2M -78.17% | 10.1M -46.90% | |
Total Current Assets | 5.5M +11.53% | 4.9M +52.10% | 3.2M -72.68% | 11.8M -42.94% | |
Accumulated Depreciation | 144,617 -25.82% | 194,952 -84.33% | 1.2M +108.54% | 596,406 +32.88% | |
Property and Plant and Equipment and Net | 1.5M +1.38% | 1.5M +17.71% | 1.3M +4.36% | 1.2M +265.20% | |
Total Long-Term Assets | 7,905 -77.58% | 35,257 +23.01% | 28,663 -18.60% | 35,211 +67.52% | |
Total Assets | 7.1M +6.94% | 6.7M +36.74% | 4.9M -63.99% | 13.5M -35.67% | |
Income Taxes Payable | 136,149 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 1.5M +74,900.00% | |
Total Current Liabilities | 1.1M +38.11% | 810,368 -54.25% | 1.8M +7.99% | 1.6M +157.43% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 3.2M -0.32% | |
Total Long-Term Liabilities | 4,540 -47.01% | 8,567 -30.47% | 12,321 -22.13% | 15,823 N/A | |
Total Liabilities | 1.1M +23.28% | 927,924 -52.99% | 2.0M -0.32% | 2.0M +210.75% | |
Retained Earnings | -41.5M +19.75% | -34.7M +28.64% | -27.0M +58.56% | -17.0M +120.89% | |
Total Stockholders Equity | 6.0M +4.29% | 5.7M +97.92% | 2.9M -74.92% | 11.5M -43.37% | |
Total Shares Outstanding | 604,534 +9.12% | 554,012 -55.29% | 1.2M -93.87% | 20.2M +0.51% | |
Cash Flow | |||||
Cash from Operating Activities | -6.1M -22.59% | -7.8M -5.94% | -8.3M +7.39% | -7.7M +77.28% | |
Capital Expenditures | 173,735 -43.37% | 306,783 -56.43% | 704,166 -41.28% | 1.2M +4,908.02% | |
Cash from Investing Activities | -173,735 -43.37% | -306,783 -56.43% | -704,166 -41.28% | -1.2M +4,908.02% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.1M -30.62% | 10.2M +819.43% | 1.1M +13,665.47% | 8,075 -99.96% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | 19.64% N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | -3,741.48% N/A | |
Return on Assets | -99.42% -25.76% | -133.92% +23.71% | -108.25% +101.09% | -53.83% N/A | |
Return on Equity | -117.02% -34.62% | -178.98% +29.79% | -137.90% +136.76% | -58.25% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | 167.77% N/A | |
Current Ratio | 4.88 -19.25% | 6.05 +232.47% | 1.82 -74.70% | 7.19 N/A | |
Cash Ratio | 4.61 -13.07% | 5.31 +325.78% | 1.25 -79.78% | 6.17 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.40 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.34 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow